Abstract:Background & aims: Ammonia levels predicted hospitalisation in a recent landmark study not accounting for portal hypertension and systemic inflammation severity. We investigated (i) the prognostic value of venous ammonia levels (outcome cohort) for liver-related outcomes while accounting for these factors and (ii) its correlation with key disease-driving mechanisms (biomarker cohort). Methods: (i) The outcome cohort included 549 clinically stable outpatients with evidence of advanced chronic liver disease. (ii) The partly overlapping biomarker cohort comprised 193 individuals, recruited from the prospective Vienna Cirrhosis Study (VICIS: NCT03267615). Results: (i) In the outcome cohort, ammonia increased across clinical stages as well as hepatic venous pressure gradient and United Network for Organ Sharing model for end-stage liver disease (2016) strata and were independently linked with diabetes. Ammonia was associated with liver-related death, even after multivariable adjustment (adjusted hazard ratio [aHR]: 1.05 [95% CI: 1.00-1.10]; p = 0.044). The recently proposed cut-off (≥1.4 × upper limit of normal) was independently predictive of hepatic decompensation (aHR: 2.08 [95% CI: 1.35-3.22]; p <0.001), non-elective liver-related hospitalisation (aHR: 1.86 [95% CI: 1.17-2.95]; p = 0.008), and - in those with decompensated advanced chronic liver disease - acute-on-chronic liver failure (aHR: 1.71 [95% CI: 1.05-2.80]; p = 0.031). (ii) Besides hepatic venous pressure gradient, venous ammonia was correlated with markers of endothelial dysfunction and liver fibrogenesis/matrix remodelling in the biomarker cohort. Conclusions: Venous ammonia predicts hepatic decompensation, non-elective liver-related hospitalisation, acute-on-chronic liver failure, and liver-related death, independently of established prognostic indicators including C-reactive protein and hepatic venous pressure gradient. Although venous ammonia is linked with several key disease-driving mechanisms, its prognostic value is not explained by associated hepatic dysfunction, systemic inflammation, or portal hypertension severity, suggesting direct toxicity. Impact and implications: A recent landmark study linked ammonia levels (a simple blood test) with hospitalisation/death in individuals with clinically stable cirrhosis. Our study extends the prognostic value of venous ammonia to other important liver-related complications. Although venous ammonia is linked with several key disease-driving mechanisms, they do not fully explain its prognostic value. This supports the concept of direct ammonia toxicity and ammonia-lowering drugs as disease-modifying treatment.

Ammonia and urea metabolism in acute liver failure: A multicentre cohort study

Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure

What every Intensivist should know about ... Ammonia in liver failure

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients

Long-Term Follow-Up of Kidney Function after Acute Liver Failure or Acute Liver Injury: A Cohort Study

Increasing serum ammonia level is a risk factor for the prognosis of critically ill patients: A multicenter retrospective cohort study

Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failure

Lactate-albumin ratio as a predictor of mortality in patients with acute on chronic liver failure in a third-level care hospital in Mexico

Predictive Factors for Acute Liver Failure or Death in Patients with Acute Liver Injury: A Longitudinal Retrospective Study

Prognostic Models for Acute Liver Failure.

Current status of etiology and outcomes of acute liver failure in India-A multicentre study from tertiary centres

Pro-adrenomedullin in Acute Decompensation of Liver Cirrhosis: Relationship with Acute-on-chronic Liver Failure and Short-Term Survival.

Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU

Extra-corporeal non-liver transplant therapies for acute liver failure: Focus on plasma exchange and continuous renal replacement therapy

Urea cycle disorders and indications for liver transplantation

A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

An international, multicenter, survey-based analysis of practice and management of acute liver failure

Ammonia-induced stress response in liver disease progression and hepatic encephalopathy

S1779 Demographics and Outcomes of Acute Liver Failure with Liver Transplantation in the United States